| Financial Year |
March 31 2023 |
| Monetary Funds |
558,387,952.23 |
| Held-for-trading Financial Assets |
455,910.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,014,589,461.88 |
| Advances to Suppliers |
199,497,540.27 |
| Other Receivables |
8,566,906.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
485,459,996.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
138,066,545.95 |
| Total Current Assets |
2,410,563,725.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
17,174,072.27 |
| Fixed Assetes |
1,181,009,291.02 |
| Under-construction Projects |
1,936,099,170.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
245,660,374.49 |
| R&D expenses |
360,512,205.58 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,223,305.33 |
| Deferred Income Tax Assets |
34,864,280.24 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,788,464,302.96 |
| Total Assets |
6,199,028,028.60 |
| Short-Term Loans |
484,841,770.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
142,139,699.04 |
| Accounts Payable |
266,030,709.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,168,395.15 |
| Taxes Payable |
31,308,939.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,420,373.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
153,549,000.00 |
| Other Current Liabilities |
14,708,313.35 |
| Sub-Total of Current Liabilities |
1,248,308,071.79 |
| Long-term Loans |
999,238,137.82 |
| Bonds Payable |
805,968,248.70 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
69,694,871.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,010,225,404.92 |
| Total Liabilities |
3,258,533,476.71 |
| Paid-In Capital(Or Share Stock) |
436,352,407.00 |
| Capital Surplus |
656,552,078.01 |
| Surplus Reserve |
191,562,903.10 |
| LESS:Treasury Stock |
66,705,218.95 |
| Undistributed Profits |
1,602,344,151.70 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,940,494,551.89 |
| Owner's Equity（Stockholder's Equity） |
2,940,494,551.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,199,028,028.60 |
